Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Correlation Between Prognostic Biomarker SLC1A5 and Immune Infiltrates in Various Types of Cancers Including Hepatocellular Carcinoma
Junsheng Zhao et al.
FRONTIERS IN ONCOLOGY (2021)
Recent progress in multidisciplinary treatment for patients with esophageal cancer
Masayuki Watanabe et al.
SURGERY TODAY (2020)
Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway
Zhiqiao Xu et al.
IUBMB LIFE (2020)
ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma
Ze Zhang et al.
BRITISH JOURNAL OF CANCER (2020)
A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells
Hee Chan Yoo et al.
CELL METABOLISM (2020)
Up-regulation of circ-SMAD7 inhibits tumor proliferation and migration in esophageal squamous cell carcinoma
Yanzhou Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Circular RNA involvement in aging: An emerging player with great potential
Hongcai Cai et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2019)
miR-622 inhibits angiogenesis by suppressing the CXCR4-VEGFA axis in colorectal cancer
Yantian Fang et al.
GENE (2019)
Circbank: a comprehensive database for circRNA with standard nomenclature
Ming Liu et al.
RNA BIOLOGY (2019)
Hsa_circ_0006938 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma
Zihao Pan et al.
AGING-US (2019)
Circular RNA profiling and its potential for esophageal squamous cell cancer diagnosis and prognosis
Liyuan Fan et al.
MOLECULAR CANCER (2019)
Circular RNA: a novel biomarker and therapeutic target for human cancers
Bo Lei et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)
Circular RNA: An emerging non-coding RNA as a regulator and biomarker in cancer
Bing Chen et al.
CANCER LETTERS (2018)
The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
Yann Cormerais et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
SLC1A5 Silencing Inhibits Esophageal Cancer Growth via Cell Cycle Arrest and Apoptosis
Jieping Lin et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Decrease of miR-622 expression promoted the proliferation, migration and invasion of cholangiocarcinoma cells by targeting regulation of c-Myc
Yi-Fei Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Glutamine Metabolism in Cancer: Understanding the Heterogeneity
Ahmad A. Cluntun et al.
TRENDS IN CANCER (2017)
MiR-622 inhibited colorectal cancer occurrence and metastasis by suppressing K-Ras
Yantian Fang et al.
MOLECULAR CARCINOGENESIS (2016)
CircInteractome: A web tool for exploring circular RNAs and their interacting proteins and microRNAs
Dawood B. Dudekulay et al.
RNA BIOLOGY (2016)
MiR-622 functions as a tumor suppressor and directly targets E2F1 in human esophageal squamous cell carcinoma
Changshan Song et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Clinicopathological significance of LAT1 and ASCT2 in patients with surgically resected esophageal squamous cell carcinoma
Hiroaki Honjo et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
The tumor microenvironment in esophageal cancer
E. W. Lin et al.
ONCOGENE (2016)
From Krebs to clinic: glutamine metabolism to cancer therapy (vol 16, pg 619, 2016)
Brian J. Altman et al.
NATURE REVIEWS CANCER (2016)
SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival
Mohamed Hassanein et al.
CLINICAL CANCER RESEARCH (2013)
Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene
Xiao-Bo Guo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Share Paper
